Gradient Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Gradient Investments's DGX Position: Q3 2024 in Review
Gradient Investments sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 3 shares — an estimated $411 sold.
Gradient Investments first reported a position in DGX in Q4 2014 and held it in 22 quarters. The position peaked at $10.8M in Q2 2020. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.
- Gradient Investments reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
- Gradient Investments sold 3 Quest Diagnostics shares in Q3 2024, an estimated $411.
- Gradient Investments first reported a position in Quest Diagnostics in Q4 2014 and held it in 22 quarters.
- Gradient Investments's Quest Diagnostics position peaked at $10.8M in Q2 2020.
- 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.
Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.